Batsuuri, Batsaikhan

Товч нэр

Бүтэн нэр

Batsuuri Batsaikhan

Латин нэр

Batsuuri Batsaikhan

Албан тушаал

Судлаач

Харьяалал

Анагаахын Шинжлэх Ухааны Үндэсний Их Сургууль

ORCID

0009-0000-4393-9657

Now showing 1 - 5 of 5

Some of the metrics are blocked by your
consent settings
P.353: Impact factors leading to renal impairment after liver transplantation: a single center consecutive 12 years’ experience.
(Wolters Kluwer, 2024-09-01)
Batsaikhan Batsuuri
;
Shiirevnyamba Avirmed
;
Chuluunbileg Batbold
;
Fidel López‐Verdugo
;
Jade M. Nunez
Introduction: Renal impairment (RI) is a common life-threatening complication of cirrhosis, affecting one in every five patients. Although LT is a lifeline for cirrhotic patients with impaired renal function, postoperative acute RI is not uncommon and is influenced by multiple factors, leading to poor outcomes. Hepatitis B virus (HBV) infection has been associated with increased risk of developing chronic kidney disease in some studies. The potential role of HBV infection in post-LT RI is unknown. This is likely due to the low prevalence of HBV infection amongst liver transplant recipients, which has been reported to be around 5% in the USA. Low- and Middle income country like Mongolia has the highest rate of hepatocellular carcinoma and hepatitis B in the world. Mongolian First liver transplant (LT) performed at First Central Hospital of Mongolia (FCHM) in September 2011 in a collaborative effort with South Korea’s Asan Medical Center. In this context, the aim of our study is identify the role of HBV infection on the incidence of renal impairment after liver transplantation. We hypothesize that patients with HBV infection will have a higher rate of RI post-LT. Methods: To determine the changes of renal function of peri- and post-LT as well as to identify risk factors for RI, we analyzed the First Central Hospital of Mongolia (FCHM) Liver Transplantation Database retrospectively, which includes patients who received LT between September 21, 2011, and December 31, 2022. Early RI was identified by measuring glomerular filtration rates by Cockcroft-Gault creatinine clearance formulation at pretransplantation, intraoperatively, 24h, 72h, 7d, 14d and 28d post LT. Results: The results revealed that female gender (OR=3.06; 95% CI=1.58–5.91), Child-Tucotte-Pugh (CTP) score B and C (OR=4.23; 95% CI=0.92–19.41), (OR=7.68; 95% CI=1.67–35.30), preoperative continuous renal replacement therapy (CRRT) (OR=5.86; 95% CI=1.1–31.21), high graft to recipient weight ratio (GRWR) (OR=3.45; 95% CI=1.23–9.63) increased the risk of RI among recipients. Moreover, recipients’ age (OR=1.07; 95% CI=1.03–1.11), Model for End-Stage Liver Disease (MELD) score (OR=1.09; 95% CI=1.03–1.16), intraoperative leukoreduced red blood cells (LR-RBC) (OR=1.09; 95% CI=1.04–1.14), platelet (PLT) (OR=1.06; 95% CI=1.00–1.12+), fresh frozen plasma (FFP) (OR=1.07; 95% CI=1.02–1.11) and postoperative LR-RBC (OR=1.09; 95% CI=1.04–1.14), cryoprecipitate transfusion (OR=1.1; 95% CI=1.01–1.19), intubated hours (OR=1.04; 95% CI=1.01–1.07) increased slightly the risk of RI. Conclusions: Female gender, high Child Pugh score, preoperative CRRT and high graft to recipient weight ratio are the primary risk factors RI after liver transplant surgery in Mongolia. The liver transplantation team at the FCHM expresses our gratitude to Prof. Sung-Gyu Lee and Liver transplantation team from the Asan Medical Center, Seoul, South Korea. Their contribution was invaluable in the form of guidance and precious knowledge transfer for developing the robust liver transplantation program in Mongolia.
Some of the metrics are blocked by your
consent settings
Renal Dysfunction After Liver Transplantation: a Single Center Study
(Mongolian National University of Medical Sciences, 2021-12-31)
Batsaikhan Batsuuri
;
Fidel López‐Verdugo
;
Bat-Ireedui Badarch
;
Suvd Nergui
;
Ariunaa Togtokh
Objectives: Mongolia is known as one of the countries with a high prevalence of viral hepatitis infection and its related liver cirrhosis and HCC. Therefor, liver transplantation (LT) surgery increases from year to year in Mongolia. Our goal was to evaluate post-transplant renal dysfunction (PTRD) and to investigate the predicting factors for renal dysfunction after LT. Methods: The impact of graft ischemic time, peri- and postoperative blood product transfusion, perioperative hemodynamics, time to extubating, intensive care length of stay, incidence of chronic renal failure, and mortality and morbidity were examined alone and then as a combined outcome. Results: Early renal dysfunction was identified by measuring serum creatinine and glomerular filtration rate. In our investigation which was a study group of patients following liver transplantation (LT), the following renal dysfunctions were found: 39% of recipients in the study had renal dysfunction, while the rest had no renal dysfunction. The average creatinine level of the recipients who had a renal dysfunction after LT, was 0.825 ± 0.24 mg/dl and the glomerular filtration rate was 111 ± 36.3 ml/min, and statistically significant. Conclusion: Preoperative kidney function plays a crucial role for postoperative renal dysfunction.
Some of the metrics are blocked by your
consent settings
P.367: Outcomes of liver transplantation: A single-center experience. (First Central Hospital of Mongolia).
(Wolters Kluwer, 2024-09-01)
Bat-Ireedui Badarch
;
Batsaikhan Bat‐Erdene
;
Batsaikhan Batsuuri
;
Ganzorig Batjargal
;
Sergelen Orgoi
Methods: This study was conducted in Transplantation Center of the First Central Hospital of Mongolia between September 2011 and May 2023 on a total 200 patients have undergone liver transplantation. Results: There were 105 female patients out of 200, age between 18 months to 62 years old, and the average MELD score was 15±5.5, length of hospital stay were 31±13.94. These transplants were for liver (living donor=189, deceased donor=11, pediatric=7). The most causes of liver transplantation were liver cirrhosis due to HBV/HDV (59.5%), hepatocellular carcinoma (22.5%), primary biliary cirrhosis (5%), and only HBV related cirrhosis, alcoholic cirrhosis. There were 23(11.5%) biliary complication, 17 (8.5%) acute cellular rejection, hepatic artery thrombosis 2 (1%), and 3 cases retransplanted. The five year survival was 87%. Conclusions: This study provides the process of liver transplantation in First Central Hospital of Mongolia, and these positive outcomes support LT as an important therapy for end-stage liver disease and early hepatocellular carcinomas. Introduction: Liver transplantation (LT) is a main treatment of end-stage liver disease. Specially developing country like Mongolia has high prevalence of HBV, HDV, and hepatocellular cancer. Liver transplant is the second-most common solid organ transplant procedure in Mongolia. This study aimed to evaluate the efficacy of liver transplantation in the First Central Hospital of Mongolia.
Some of the metrics are blocked by your
consent settings
Risk Factors of Delayed Graft Function in Patients with Kidney Transplantation
(Mongolian National University of Medical Sciences, 2025-09-30)
Oyunpurev Erdenechimeg
;
Tuvshinbayar Javzan
;
Uugan-Erdene Amarbold
;
Od-Erdene Lkhaakhuu
;
Kishgee Tseren
Objective: In Mongolia, since 2006, kidney transplantation has been performed regularly, with more than 400 people having undergone this surgery. This preliminary study aimed to investigate the incidence of delayed graft function after kidney transplantation in Mongolia and to identify the associated risk factors. Methods: This study used a retrospective approach, gathering data from monitoring records. We applied the Student t-test, one-way ANOVA, Wilcoxon rank sum test, Kruskal-Wallis rank test, Spearman correlation, multivariate linear regression, and logistic regression. Results: Of the 268 recipients, 198(74.44%) were male. There were 14 total cases of DGF, of which 13 were transplanted from brain-dead donors. Postoperative urine outcome decreases by 120 mL for a 1-year increase in donor age (b = -120, p= 0.033). A 1-minute increase in cold ischemia time results in a 20-mL decrease in urine output (b = -20, p= 0.002). Donor age>40 increased the risk by 1.2 times (OR=1.2, p= 0.05), and brain-dead donor increased the risk by 19.37 times (OR=19.37, p= 0.0001), while recipient age<35 reduced the risk by 5 times (OR=0.2, p= 0.039). Conclusion: Our study found that risk factors such as older donor and recipient age, prolonged cold and warm ischemia times, and brain-dead donor status were associated with an increased risk of delayed graft function.
Some of the metrics are blocked by your
consent settings
A decade of liver transplantation in Mongolia: Economic insights and cost analysis
(Springer Science and Business Media LLC, 2024-07)
Tsengel, Amarjargal
;
Orgoi, Sergelen
;
Damdinbazar, Otgonbayar
;
Badarch, Bat-Ireedui
;
Ganbold, Urnultsaikhan
BACKGROUND: Mongolia introduced liver transplantation 10 years ago, becoming the 46th country globally to successfully perform this procedure. However, the cost of liver transplantation treatment remains expensive in Mongolia, a lower-middle-income country. Thus, the need to calculate the cost of liver transplants, a highly-valued treatment, forms the basis for this study. METHODS: This study employed a retrospective research design with secondary data. The primary dataset comprised 143 cases of liver transplantation performed at the First Central Hospital of Mongolia between 2011 and 2021. RESULTS: The average cost of a liver transplant in Mongolia is $39,589 ± 10,308, with 79.6% being direct costs and 20.4% indirect costs. Of the direct costs, 71% were attributed to drugs, medical equipment, and supplies, while 8.6% accounted for salaries. In terms of the Model of End-Stage Liver Disease (MELD) scores, treatment costs were $39,205 ± 10,786 for patients with MELD ≤ 14 points, $40,296 ± 1,517 for patients with MELD 15-20 points, $39,352 ± 8,718 for patients with MELD 21-27 points, and $39,812 ± 9,954 for patients with MELD ≤ 28 points, with no statistically significant difference (P = 0.953). However, when calculated according to the Child-Turcotte-Pugh (CTP) score classification, treatment cost for CTP-A patients was $35,970 ± 6,879, for CTP-B patients $41,951 ± 12,195, and for CTP-C patients $37,396 ± 6,701, which was statistically significant (Р=0.015). CONCLUSION: The average cost of liver transplantation treatment in Mongolia was $39,589. Despite medical facilities' capacity to treat up to 50 patients annually, the waiting list exceeds 300 individuals, highlighting significant unmet healthcare needs.
Scopus© Citations 2

Batsuuri, Batsaikhan

Filters

Settings

Sort By

Results per page